Online Education
- Home
- Online Education
Important Note
You will need to login first in order to enroll or view an activity. Login Here
*Note: ✔ = Contact Hours Provided AND ✖ = No Contact Hours Provided
A School Nurse's Guide to Bleeding Disorders: Hemophilia
- Credits: 0.75 (ANCC)
- Expiration Date: May 27, 2024
A School Nurse's Guide to Bleeding Disorders: Hemophilia Details
Activity Number and Title
22HT00053 A School Nurses Guide to Bleeding Disorders: Hemophilia
Release Date
May 27, 2022
Expiration Date
5:00 PM Eastern, May 27, 2024
The estimated time to complete this activity is 45 minutes.
Purpose Statement
This online learning activity aims to enable the learner to develop basic knowledge and skills regarding etiology, inheritance, severity, and treatment of hemophilia, recognition of hemophilia symptoms, and use of strategies to promote a safe and positive learning environment.
Activity Description
The activity is designed for school nurses, nurse practitioners, and other school personnel who require basic knowledge and skill to effectively practice and teach in schools attended by a student with hemophilia. This involves debunking common myths that persist about hemophilia and replacing those myths with factual information concerning the etiology, inheritance, severity, and treatment of hemophilia. It includes information on identifying prevalent locations and symptoms of bleeding in hemophilia. Finally, the activity reviews strategies that may be implemented in the school setting to promote a safe and positive learning environment for the student with hemophilia.
Target Audience
This accredited continuing education activity is designed for nurses and nurse practitioners who practice in schools attended by a student with hemophilia. It may also be helpful to teachers, physical education and sports coaches, administrators, guidance counselors, and other educators and healthcare professionals needing an introduction to school related considerations in hemophilia.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Dispel common misconceptions about hemophilia
- Review basic information about the etiology, inheritance, and severity of hemophilia
- Identify prevalent locations and symptoms of joint and muscle bleeding in hemophilia
- Describe hemophilia treatment strategies and medications utilized and avoided in hemophilia management
- Discuss guidelines for participation in physical activity and sports by persons with hemophilia
- Integrate reasonable accommodations in the school setting to promote a safe and positive learning environment for the student with hemophilia
- Explain the role of the Hemophilia Treatment Center as a resource for support for schools attended by a student with hemophilia
Faculty
- Lisa Bowman, RN, BSN, ASN
- Molly Simmons, RN, BSN
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 0.75 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
An Overview of the Background, Inheritance and Pathophysiology of von Willebrand Disease
- Credits: NA
- Expiration Date: NA
An Overview of the Background, Inheritance and Pathophysiology of von Willebrand Disease Details
Activity Number and Title
An Overview of the Background, Inheritance and Pathophysiology of von Willebrand Disease
Release Date
October 24, 2022
The estimated time to complete this activity is 45 minutes.
Purpose Statement
The purpose of this online learning activity is to enable the learner to develop an understanding of von Willebrand disease (VWD) by examining the discovery and evolution of scientific knowledge about VWD; genetic inheritance of the bleeding disorder; production, structure, and functions of von Willebrand factor (VWF); and characteristics of the different types of VWD.
Educational Objectives
- Review the history of von Willebrand Disease (VWD), including its discovery and evolution of scientific understanding of the bleeding disorder
- Discuss the epidemiology, inheritance, and diagnosis of VWD
- Examine the production, structure, and functions of von Willebrand factor (VWF)
- Differentiate the types and subtypes of VWD, including types 1, 2, and 3
Target Audience
This enduring material is intended for nurses and other healthcare professionals employed within the federally recognized U.S. hemophilia treatment center network (USHTCN) seeking training on von Willebrand disease (VWD) relating to the history and evolution of our understanding of the condition, the role of von Willebrand factor (VWF), and the differentiation of the multiple classifications of VWD.
Topics/Content
This online learning activity provides an outline of the history, inheritance, and pathophysiology of von Willebrand Disease (VWD). It includes a description of how VWD was discovered and traces the evolution of knowledge about the bleeding disorder. It also details the genetic inheritance of VWD and the likelihood that offspring of an affected parent will be born with VWD. The activity examines the production and many functions of von Willebrand factor, described as the Jedi knight of the bloodstream. Finally, the activity differentiates the types of VWD on the basis of laboratory features. VWF function, VWF multimer quantity and quality, and symptoms.
Faculty w/ credentials
- Roshni Kulkarni, MD
- Usha M. Reddy, MD
- Bruce L. Evatt, MD
- Connie H. Miller, PhD
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813, toll-free 877-256-8837, or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Gene Therapy for Providers 101
- Credits: 0.75 (ACCME), 0.75 (ANCC), 0.75 (ACPE)
- Expiration Date: October 13, 2023
Gene Therapy for Providers 101 Details
Activity Number and Title
22HT57252 - Gene Therapy for Providers 101
Release Date
October 14, 2022
Expiration Date
5:00 PM Eastern, October 13, 2023
The estimated time to complete this enduring material is 45 minutes.
Purpose Statement
The purpose of this activity is to enable learners to develop basic knowledge of gene therapy for hemophilia, thereby enhancing learner competence to discuss gene therapy with patients who may benefit from this emerging treatment.
Activity Description
This learning activity provides basic education on hemophilia gene therapy, including the aims of gene therapy; the packaging, delivery, and activity of the replacement genes; and the means by which the replacement genes lead to production and/or availability of normal clotting factor in persons with hemophilia. The module will also review information that may be particularly important when discussing hemophilia gene therapy with patients, such as knowledgeable informed consent, outcomes data, and potential risks and benefits.
Target Audience
This accredited continuing education activity is designed for multidisciplinary providers at hemophilia treatment centers, including nurses, physicians, pharmacists, physical therapists, social workers, and genetic counselors providing care to persons with hemophilia A and hemophilia B.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Describe a pathway to preparedness for gene therapy from education of the multidisciplinary healthcare team to clinical delivery
- Provide an overview of the goal of gene therapy for hemophilia
- Explain the elements of gene therapy (i.e. packaging, administration, mechanism of action)
- Define the profile of gene therapy candidates with FVIII deficiency and FIX deficiency
- Review known adverse effects from completed and ongoing clinical trials
- Articulate critical considerations for the multidisciplinary healthcare team in providing care for patients receiving gene therapy
- Discuss issues related to obtaining knowledgeable informed consent and counseling patients
Faculty
- Steven W. Pipe, MD
- Shelley Crary, MD, MSCS
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHARMACISTS (PharmDs/RPhs)
The University of Nebraska Medical Center designates this activity for 0.75 ACPE contact hours. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN # JA0000319-9999-22-018-H01-P
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 0.75 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Gene Therapy for Providers 201
- Credits: 1 (ACCME), 1.0 (ANCC), 1.0 (ACPE)
- Expiration Date: October 13, 2023
Gene Therapy for Providers 201 Details
Activity Number and Title
22HT57253 - Gene Therapy for Providers 201
Release Date
October 14, 2022
Expiration Date
5:00 PM Eastern, October 13, 2023
The estimated time to complete this activity is 60 minutes.
Purpose Statement
The purpose of this activity is to enable HTC multidisciplinary staff and institutional stakeholders to gain knowledge on the steps necessary to prepare an institution to administer AAV-mediated gene therapy for hemophilia.
Activity Description
This learning activity is a process-oriented intermediate course that will guide HTC staff through the steps an institution must take to prepare to administer hemophilia gene therapy upon commercial availability of these products.
Target Audience
This accredited continuing education activity is designed for HTC multidisciplinary staff (physicians, physician assistants, nurses, nurse practitioners, physical therapists, social workers, pharmacists, geneticists, genetic counselors, infusion room staff) and institutional stakeholders (e.g., HTC administrators and directors, clinic and pharmacy billing staff, insurance coordinators).
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Identify patients who are eligible for AAV-mediated gene therapy
- Discuss key concepts involving education and shared decision-making for gene therapy
- Identify logistical/infrastructure requirements to procure, reconstitute and administer gene therapy at a dosing site
- Articulate the regional approach of preparing for gene therapy administration
- Distinguish the roles and responsibilities within the HTC team involved in the safety and efficacy assessments during short-and long-term monitoring before and after gene therapy
- Describe approaches to prevention, diagnosis, and treatment of vector-induced transaminitis after gene therapy
Faculty
- Rebecca Kruse-Jarres, MD, MPH
- Ulrike Margret Reiss, MD
- Courtney Dawn Thornburg, MD, MS
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia and Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHARMACISTS (PharmDs/RPhs)
The University of Nebraska Medical Center designates this activity for 1 ACPE contact hours. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN # JA0000319-9999-22-019-H01-P
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Gene Therapy for Providers 301
- Credits: 1 (ACCME), 1.0 (ANCC), 1.0 (ACPE)
- Expiration Date: October 13, 2023
Gene Therapy for Providers 301 Details
Activity Number and Title
22HT57254 Gene Therapy for Providers 301
Release Date
October 14, 2022
Expiration Date
5:00 PM Eastern, October 13, 2023
The estimated time to complete this enduring material is 60 minutes.
Purpose Statement
The purpose of this activity is to enable HTC multidisciplinary staff and hospital staff to support patients and their families as they consider hemophilia gene therapy, including education of patients and families on basic concepts in hemophilia gene therapy; administrative preparedness for providers; and short- and long-term care demands.
Activity Description
This learning activity is a process-oriented intermediate course that will guide HTC staff through the steps an institution must take to prepare to administer hemophilia gene therapy upon commercial availability of these products.
Target Audience
This accredited continuing education activity is designed for physicians, physician assistants, nurses, nurse practitioners, physical therapists, social workers, pharmacists, and infusion room staff.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Discuss introductory concepts in hemophilia gene therapy
- Outline the process of preparing patients, hemophilia treatment centers, and hospital systems for the administration of gene therapy
- Explain the steps necessary for multidisciplinary team members to engage in shared patient-centered and population focused problem solving when procuring a hemophilia gene therapy product, preparing the product, and infusing the patient safely
- Discuss short term monitoring, specifically immediately after infusion and during the first three months of follow up
- Discuss long term monitoring, specifically from 3 to 24 months post infusion and > 24 months post infusion
Faculty
- Doris V. Quon, MD
- Lindsey A. George, MD
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHARMACISTS (PharmDs/RPhs)
The University of Nebraska Medical Center designates this activity for 1 ACPE contact hours. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN # JA0000319-9999-22-020-H01-P
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Hemophilia in Pictures Details
Activity Title
Hemophilia in Pictures
Original Release Date
2005
Purpose Statement
The purpose of Hemophilia in Pictures is to provide basic knowledge about hemophilia through pictures and easy-to-understand information.
Activity Description
This online learning module covers a range of topics, including an introduction to hemophilia, assessing and managing bleeds, treatment of bleeds, staying healthy and preventing bleeds, and venipuncture and home therapy.
Target Audience
Hemophilia in Pictures is for hemophilia educators and people with hemophilia alike. The information is basic and is provided through pictures and easy-to-understand language, so it is accessible to anyone.
Educational Objectives
Hemophilia in Pictures has many goals. Please refer to the HIP Educators Guide to learn more about the educational goals for Educators as well as People with Hemophilia.
Faculty
- Lara Oyesiku, Chair of the HIP Working Group and Nurse's Committee, England
- Martin Bedford, Educational Advisor, England
- Annie Gillham, Nurse Advisor, South Africa
- Dr. Peter Jones, Medical Advisor, England
- Kathy Mulder, Physiotherapy Advisor, Canada
- David Page, Educational Advisor, Canada
- Laurie Blackstock, WFH Education Officer
Note
Upon launching the presentation, there are three handouts available for you to print or save for future reference: Educator Guide, Educator Glossary, and On Screen Notes.
To access the handouts, click on the slide notes and resources.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Hereditary Hemorrhagic Telangiectasia: Right Under Your Nose
- Credits: 1.0 (ACCME), 1.0 (ANCC)
- Expiration Date: May 31, 2024
Hereditary Hemorrhagic Telangiectasia: Right Under Your Nose Details
Activity Number and Title
21HT50146 Hereditary Hemorrhagic Telangiectasia: Right Under Your Nose
Release Date
June 1, 2022
Expiration Date
5:00 PM Eastern, May 31, 2024
The estimated time to complete this activity is 60 minutes.
Purpose Statement
This online learning activity aims to enable the learner to gain knowledge and expertise regarding hereditary hemorrhagic telangiectasia (HHT), including inheritance and pathophysiology, screening guidelines, management, and the importance of the multidisciplinary approach in caring for these patients.
Activity Description
This online learning activity provides a detailed introduction to hereditary hemorrhagic telangiectasia (HHT) appropriate for an audience of multidisciplinary health care providers involved in the team-based care of patients with HHT. This overview includes information on the genetic inheritance and pathophysiology of HHT as well as the widely-used Curaçao diagnostic criteria to determine if a person has HHT, consensus screening guidelines for HHT management, and an explanation of the importance of a multidisciplinary approach to care of patients with HHT. This activity incorporates case scenarios and interactive questions to encourage active learning through application of the content.
Target Audience
This accredited continuing education activity is designed for physicians, physician assistants, nurse practitioners, nurses, and other multidisciplinary team members who care for patients with hereditary hemorrhagic telangiectasia.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Identify the Curaçao criteria for determining the likelihood of Hereditary Hemorrhagic Telangiectasia (HHT) in an undiagnosed individual
- Describe HHT genetics and pathophysiology
- Discuss the international consensus screening guidelines for HHT management
- Review management of epistaxis, iron deficiency, and pulmonary arteriovenous malformations (PAVMs) in HHT
- Explain the importance of an HHT Center-driven multidisciplinary approach in caring for patients with HHT
Faculty
- Manjusha Kumar, MD
- Magdalena Lewandowska, MD
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hours. This activity is provided for 0.15 contact hours related to pharmacotherapeutic content. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
How Does Blood Clot? Details
Title
How Does Blood Clot?
Purpose Statement
The purpose of this activity is to enable the learner to improve understanding of and increase interest in the basic concepts involved in the complex coagulation process to ultimately improve patient care.
Educational Objectives
- Examine the coagulation process from the point of injury to clot resolution.
- Evaluate the platelet reaction step of normal hemostasis.
- Differentiate among the three coagulation pathways, including the various clotting factors that participate in hemostasis.
Target Audience
Nurses and other healthcare staff employed within or affiliated with the U.S. Hemophilia Treatment Center (HTC) network.
Topics/Content
An animated module illustrating the coagulation cascade.
Faculty w/ credentials
- Roshni Kulkarni, MD
- Usha M. Reddy, MD
- Bruce L. Evatt, MD
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813, toll-free 877-256-8837, or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Please note: This program requires FLASH PLAYER. If your computer does not have FLASH PLAYER, or does not allow such files to play, you will not be able to view this program. You will need to speak to your institutions Information Technology department about enabling or installing FLASH PLAYER onto your computer.
Is That OK? Ethical Dilemmas In Our Community
- Credits: 0.5 (ANCC)
- Expiration Date: October 18, 2024
Is That OK? Ethical Dilemmas In Our Community Details
Activity Number and Title
22HT00069 Is That Ok? Ethical Dilemmas In Our Community
Release Date
October 20, 2022
Expiration Date
5:00 PM Eastern, October 21, 2024
The estimated time to complete this activity is 30 minutes.
Purpose Statement
The purpose of this online learning activity is to enable the learner to enhance competencies to recognize ethical dilemmas, identify the relevant ethical concepts and principles, and apply the ethical decision-making process to resolve these dilemmas.
Activity Description
This online learning activity provides healthcare professionals and others an opportunity to gain knowledge about ethical theories, key ethical concepts, and the opportunity to apply these theories and concepts through case study examples.
Target Audience
This accredited continuing education activity is designed for members of the hemophilia treatment center (HTC) multidisciplinary comprehensive care team including Nurses and Social Workers.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Define ethics and the essential questions underlying ethical theories
- Distinguish four settings in which ethics and ethical action are ongoing considerations
- Interpret key ethical principles and the ethical decision-making process
- Identify relevant ethical principles in common ethical dilemmas encountered by persons with bleeding disorders and their providers
Faculty
- Kristie Ostash, MD
- Sabrina Farina, LMSW
- Jim Munn, MS, BS, BSN, RN-BC
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 0.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Physical Therapy and Comprehensive Care
- Credits: 0.75 (ANCC), 0.075 (CPTA)
- Expiration Date: June 15, 2023
Physical Therapy and Comprehensive Care Details
Activity Number and Title
20CE169 - Physical Therapy and Comprehensive Care
Release Date
June 15, 2021
Expiration Date
5:00 PM Eastern, June 16, 2023
The estimated time to complete this activity is 45 minutes.
Purpose Statement
The purpose of this module is to enable the learner to gain knowledge of the physical therapists role in providing comprehensive care at U.S. hemophilia treatment centers (HTCs), as well as the resources and opportunities available to physical therapists in the U.S. HTC network.
Activity Description
The activity begins with a brief description of the U.S. hemophilia treatment center (HTC) network and the comprehensive care model utilized at these centers. It then introduces the Physical Therapy Working Group (PTWG) of the National Hemophilia Foundation and resources available from this group, including recommendations on physical therapy evaluation elements as well as physical therapy treatment guidelines for bleeding disorder management. The activity also explains the physical therapists contribution to comprehensive care, including his or her role in helping patients select appropriate sports, physical activity, and employment.
Target Audience
This enduring material is intended for physical therapists, physical therapist assistants, nurses, nurse practitioners, and other health care providers who are involved with the federally recognized U.S. Hemophilia Treatment Center, or HTC, network or otherwise engaged in comprehensive care and/or physical therapy management of individuals with hemophilia and other bleeding disorders.
This activity assumes that the learner possesses fundamental knowledge of the musculoskeletal and neurological systems and a basic understanding of bleeding disorders and the comprehensive care model. Learners who do not meet these criteria may wish to complete the PartnersPRN activity, Understanding Hemophilia, prior to completion of this module on physical therapy and comprehensive care.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Discuss the history of the U.S. Hemophilia Treatment Center (HTC) network and the components of the multidisciplinary comprehensive care model employed by HTCs
- Explain the role of the Physical Therapy Working Group in the U.S. HTC network and resources available from this group
- Review funding opportunities available to physical therapists working in the U.S. HTC network
- Validate physical therapy as a key discipline in the multidisciplinary comprehensive care of people with bleeding disorders
- Discuss Physical Therapy Working Group guidelines for the management of bleeding disorders and the essential components of various team members roles within the comprehensive clinic as prescribed by the Physical Therapy Working Group
- Articulate the importance of sports and physical activity for persons with bleeding disorders and the physical therapists role in helping patients select appropriate activities
- Describe vocational considerations often discussed between the physical therapist and patient when treating persons with bleeding disorders
Faculty
- Stacie Akins, PT, MHS
- Kimberly Baumann, MPT
- Sherry Herman-Hilker, PT, MS
- Jennifer Newman, MSPT
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center on behalf of the Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 0.75 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
This activity (CPTA #22-303) has been approved by the California Physical Therapy Association (CPTA) for 0.075 CEUs. While many states recognize continuing education credits from CPTA, please verify with your state Board that these credits are acceptable in your state. To learn more about CPTA, visit https://www.ccapta.org.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Physical Therapy in the Care of Persons with Bleeding Disorders
- Credits: 1.5 (ANCC), 0.15 (CPTA)
- Expiration Date: June 15, 2023
Physical Therapy in the Care of Persons with Bleeding Disorders Details
Activity Number and Title
20CE168 - Physical Therapy in the Care of Persons with Bleeding Disorders
Release Date
June 15, 2021
Expiration Date
5:00 PM Eastern, June 16, 2023
The estimated time to complete this activity is 90 minutes.
Purpose Statement
The purpose of this online learning module is to enable the learner to increase their knowledge on the musculoskeletal concerns, potential complications, and physical therapy management of bleeding disorders.
Activity Description
After providing a review of basic information about hemophilia and von Willebrand disease, this learning module describes signs and symptoms of hemophilic bleeding, the complications associated with recurrent bleeding, physical therapy interventions for acute and chronic musculoskeletal complications of hemophilia, and imaging techniques including X-ray, MRI, and musculoskeletal ultrasound, which may be used to assess musculoskeletal status in patients with bleeding disorders.
Target Audience
This enduring material is intended for physical therapists, physical therapist assistants, nurses, nurse practitioners, and other health care providers who are involved with the federally recognized U.S. Hemophilia Treatment Center, or HTC, network or otherwise engaged in comprehensive care and/or physical therapy management of individuals with hemophilia and other bleeding disorders.
This activity assumes that the learner possesses fundamental knowledge of the musculoskeletal and neurological systems and a basic understanding of bleeding disorders and the comprehensive care model. Learners who do not meet these criteria may wish to complete the PartnersPRN activity, "Understanding Hemophilia", prior to completion of this module on physical therapy and comprehensive care.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Summarize basic information on the clinical picture of hemophilia and von Willebrand disease
- Identify signs and symptoms of acute and chronic musculoskeletal bleeding including hemarthroses and muscle bleeding
- Evaluate the complications of recurrent hemarthroses including chronic synovitis, cartilage destruction, and hemophilic arthropathy
- Discuss physical therapy interventions for acute bleeding events and chronic musculoskeletal complications of bleeding disorders and how the multidisciplinary team can help implement these strategies to improve patient outcomes
- Differentiate imaging techniques and their use to assess musculoskeletal status in patients with bleeding disorders
Faculty
- Stacie Akins, PT, MHS
- Kimberly Baumann, MPT
- Sherry Herman-Hilker, PT, MS
- Jennifer Newman, MSPT
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center on behalf of the Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 1.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
This activity (CPTA #22-302) has been approved by the California Physical Therapy Association (CPTA) for 0.15 CEUs. While many states recognize continuing education credits from CPTA, please verify with your state Board that these credits are acceptable in your state. To learn more about CPTA, visit https://www.ccapta.org.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
The Role of the Nurse in Hemophilia Care Details
Activity Title
The Role of the Nurse in Hemophilia Care
Purpose Statement
The purpose of this module is to familiarize the learner with the critical role nurses play worldwide in the multidisciplinary care team.
Educational Objectives
- Examine the critical and variable role of the nurse in the care of people with hemophilia.
- Review the role responsibilities of the nurse related to education, care delivery, coordination of the healthcare team, and support of patient and family to learn to live with hemophilia.
Topics/Content
While there are some responsibilities that are universal for all nurses, there is also a great deal of variation in the role and responsibilities of nurses in hemophilia care. This learning module describes those roles and responsibilities and some of the variation that may occur throughout the world.
Faculty w/ credentials
- World Federation of Hemophilia
Date of Original Release
June 18, 2013
Note
This module was created to describe the worldwide variation in the role and responsibilities of nurses in hemophilia care.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Advance Care Planning and Advance Directives
- Credits: 1.0 (ACCME),1.0 (ANCC),1.0 (ASWB)
- Expiration Date: August 29, 2024
Advance Care Planning and Advance Directives Details
Activity Number and Title
22HT54278 - Advance Care Planning and Advance Directives
Release Date
August 29, 2022
Expiration Date
5:00 PM Eastern, August 29, 2024
The estimated time to complete this activity is 60 minutes.
Purpose Statement
The activity aims to enable the learner to understand the process of advance care planning, the associated healthcare decision making document aids, and additional resources to assure patient's wishes are elicited and documented in a meaningful manner.
Activity Description
This learning activity provides education on the development of a robust Advance Care Planning (ACP) program and covers the goals, barriers, and enabling strategies to implement an ACP program with patients. This module also offers many ACP resource documents, patient decision aids, and communication tools and techniques for how to facilitate these ACP conversations with patients to honor their wishes when it comes to their goals of care during this period of life.
The content level of this activity is intermediate.
Target Audience
This accredited continuing education activity is designed for physicians, advance practice clinicians, social workers, and nurses caring for patients with bleeding disorders. This activity will additionally target care managers, spiritual care specialists, and other multidisciplinary providers involved in caring for patients with bleeding disorders.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Discuss complexities and demands of today's older adults to both live and die well?
- Describe various advance care planning program implementation strategies
- Employ completion of advance care planning documents with patients
- Facilitate advance care planning conversations with patients and families using various communication tools and techniques
- Identify advance care planning reimbursement opportunities with CMS and various insurance companies?
Faculty
- Stephanie VanSlyke, BA, RN, HEC-C
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 80% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 1.0? AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour(s). Nurses should only claim credit for the actual time spent participating in the activity.
SOCIAL WORKERS
As a Jointly Accredited Organization, University of Nebraska Medical Center is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credits.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection Internet browser (current version) - Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Hemophilia 101 for Nonclinical Staff at HTCs Details
Activity Title
Hemophilia 101 for Nonclinical Staff at HTCs (non CE)
Purpose Statement
This module is designed to provide information about the U.S. federally funded hemophilia treatment center (or HTC) network (referred to as USHTCN) and the multidisciplinary comprehensive care provided at HTCs. The module also reviews the key concepts of data collection and research at HTCs. Providing an overview of the scientific precepts of hemophilia, the module further explains how data and clinical care are integrated and pertinent to the important role of nonclinical staff at HTCs.
Educational Objectives
- Identify different parts of the federally funded U.S. HTC network
- Examine key components of the hemophilia comprehensive care model
- Review data collection requirements for linking the comprehensive care model to health outcomes
- Explain general scientific precepts of bleeding disorders
- Evaluate how data and clinical care are integrated and pertinent to the role of nonclinical staff
Target Audience
This module is designed for nonclinical professionals in the HTC network, including data collection personnel, administrators, HTC staff interacting with 340B programs.
Topics/Content
This module is divided into three sections:
Section I covers the U.S. Hemophilia Treatment Center Network (USHTCN) and the multidisciplinary comprehensive care model practiced at HTCs,
Section II reviews the data collection and research at HTCs, and
Section III discusses the clinical and medical issues in hemophilia at a 101 level and the importance of these issues to nonclinical staff.
Faculty w/ credentials
- Brenda Riske, MS, MBA, MPA
- Regina Butler, RN
- Jim Munn, RN, MS
Date of Original Release
January 30, 2015
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813, toll-free 877-256-8837, or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High speed internet connection
- Any one Internet browser:
- Firefox (Most Current Version)
- Safari (Most Current Version)
- Google Chrome (Most Current Version)
- MS Internet Explorer (Most Current Version)
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
- Cookies and JavaScript must be enabled in all browsers.
- All browsers must have flash plug in installed and enabled.
MASAC Pain Initiative Task Force Pain Management Guidelines for Bleeding Disorders
- Credits: 2.0 (ACCME), 2.0 (ANCC), 2 (ASWB), 0.2 (CPTA)
- Expiration Date: December 15, 2023
MASAC Pain Initiative Task Force Pain Management Guidelines for Bleeding Disorders Details
Activity Number and Title
21HT50199 - MASAC Pain Initiative Task Force Pain Management Guidelines for Bleeding Disorders
Release Date
January 10, 2022
Expiration Date
5:00 PM Eastern, December 15, 2023
Note: CPTA #21-640 expires December 15, 2022
The estimated time to complete this activity is 120 minutes.
The content level of this activity is intermediate.
Purpose Statement
The purpose of this enduring material is to enable the learner to gain knowledge on the opioid guidance document published in early 2020 by the Medical and Scientific Advisory Council (or MASAC).
Activity Description
In this module, there are several aspects of pain management that will be addressed. Foremost is to familiarize you with the MASAC opioid guidance document established in 2020. In addition, we will describe the importance of standardized assessment of pain. This activity will help you to determine goals for pain management and how the roles of each team member can help incorporate non-pharmacological pain management options. Lastly, opioid issues including when and how to start opioids for pain management and monitoring systems that will assist you will be covered in the modules. To enhance the learning, case studies will be examined.
Target Audience
This enduring material is intended for physicians, physician assistants, nurse practitioners, nurses, social workers, physical therapists, and other interested members of the bleeding disorder comprehensive care team.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Discuss the MASAC opioid guidance document
- Describe the importance of standardized assessment of pain in persons with bleeding disorders
- Determine realistic functional goals for pain management and how the roles of each team member can help incorporate non-pharmacological pain management options in a multimodal fashion
- Utilize appropriate state monitoring tools, as well as additional monitoring methods for evaluation of pain management progress
Faculty
- Angela Lambing, MSN, ANP, GNP
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 80% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 2.0 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
As a Jointly Accredited Organization, University of Nebraska Medical Center is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Nebraska Medical Center maintains responsibility for this course. Social workers completing this course receive 2 continuing education credits.
PHYSICAL THERAPISTS
This activity is approved for physical therapy continuing education units (CEUs) through the California Physical Therapy Association (CPTA) (Approved for 0.2 CEUs by CPTA #21-640). While many states recognize continuing education credits from CPTA, please verify with your state Board that these credits are acceptable in your state. To learn more about CPTA, visit https://www.ccapta.org.
Financial Support
No commercial support was received for this activity. Supported by an educational grant from the National Hemophilia Foundation.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Nutritional Considerations in Common Comorbidities of Hemophilia
- Credits: 0.75 (ANCC)
- Expiration Date: May 22, 2023
Nutritional Considerations in Common Comorbidities of Hemophilia Details
Activity Number and Title
21HT00077 - Nutritional Considerations in Common Comorbidities of Hemophilia
Release Date
May 21, 2021
Expiration Date
5:00 PM Eastern, May 22, 2023
The estimated time to complete this activity is 45 minutes.
Purpose Statement
This online learning activity aims to enable learners to develop competencies regarding the roles and responsibilities of the Registered Dietitian Nutritionist as a member of the multidisciplinary comprehensive care team and to gain knowledge of nutritional considerations in common comorbidities of hemophilia, to include hepatitis C, HIV, iron deficiency anemia, osteoporosis, obesity, and dyslipidemia.
Activity Description
This learning activity introduces the RDN as a member of the extended hemophilia comprehensive care team at U.S. Hemophilia Treatment Centers (HTCs). Topics include discussion of the roles and responsibilities of the RDN or other qualified individual, components of the nutrition assessment administered by this professional, nutrition objectives and dietary interventions for common comorbidities of hemophilia, and important considerations and discussion points on use of dietary supplements among persons with hemophilia.
Target Audience
This online learning activity is intended for registered dietitian nutritionists, nurses, physical therapists, social workers, and other members of the multidisciplinary comprehensive care team at U.S. Hemophilia Treatment Centers, or HTCs, who are involved in or support the nutritional health of patients with hemophilia.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Discuss the roles and responsibilities of the Registered Dietitian Nutritionist on the hemophilia comprehensive care team
- Examine the components of the nutrition assessment administered by the Hemophilia Treatment Center Registered Dietitian Nutritionist
- Evaluate nutrition objectives and dietary interventions for common comorbidities of hemophilia
- Identify important considerations and discussion points for persons with hemophilia regarding dietary supplements
Faculty
- Tina Willis, MA, RDN
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 0.75 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Understanding Hemophilia
- Credits: 2.0 (ANCC), 2.00 (AAPA)
- Expiration Date: February 23, 2024
Understanding Hemophilia Details
Activity Number and Title
22HT00046 Understanding Hemophilia
Release Date
February 24, 2022
Expiration Date
5:00 PM Eastern, February 23, 2024
The estimated time to complete this activity is 120 minutes.
Purpose Statement
"Understanding Hemophilia" is a 6-part online learning activity that aims to enable clinicians at U.S. Hemophilia Treatment Centers to gain knowledge and develop expertise on the pathogenesis, inheritance, symptoms, potential complications, and clinical management of hemophilia.
Activity Description
This 6-part online learning activity introduces basic concepts of hemophilia.
Part 1: Pathogenesis & Inheritance examines the coagulation system and processes, the deficit in hemophilia that interferes with clot formation, differences among types of hemophilia, and the sex-linked inheritance pattern of hemophilia.
Part 2: Symptoms & Sequelae distinguishes bleeding patterns and clinical presentation of hemophilia based on severity, differentiates types of bleeding episodes, and discusses physical/psychosocial sequelae of hemophilia.
Part 3: Factor Concentrates & Hemophilia Management discusses episodic and prophylactic management of hemophilia with clotting factor concentrate, different factor therapy protocols, and nursing considerations in administration of clotting factor concentrates.
Part 4: Introduction to Inhibitors explains the immune response and inhibitor development, signs/symptoms and risk factors of inhibitors, the impact of inhibitors on persons with hemophilia, inhibitor treatment strategies and challenges, and the positive health outcomes of immune tolerance induction therapy.
Part 5: Emicizumab covers the novel agent emicizumab, including its indications, mechanism of action, dosing options, lab considerations; as well as management of breakthrough bleeding, the boxed warning of emicizumab, use of emicizumab concurrently with bypassing agents, and potential considerations in the management of persons with hemophilia with or without inhibitors who utilize emicizumab.
Part 6: Carrier Considerations reviews hemophilia sex-linked genetics and introduces recommendations for the management of carriers and women with hemophilia, neonatal diagnosis and circumcision in males with hemophilia, and key considerations of postpartum management of carriers and women with hemophilia.
Target Audience
This enduring material is intended for nurses, nurse practitioners, physician assistants, and other clinical staff within the federally recognized U.S. Hemophilia Treatment Center (HTC) network who wish to develop an understanding of basic concepts of hemophilia. The activity is particularly appropriate for clinicians within their first six months of employment at an HTC.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Describe the pathogenesis and inheritance patterns concerning the different factor deficiencies in hemophilia including the symptoms and sequelae that may occur
- Discuss the target factor levels for situational bleeding episodes in conjunction with the appropriate factor replacement protocols, prophylactic treatments, and nursing considerations in administration of clotting factor concentrates
- Review the development and impact of inhibitors on persons with hemophilia, including signs and symptoms, risk factors, treatment implications, and nursing considerations
- Summarize the MASAC recommendations on the use of Emicizumab such as the indications, management approaches, and concurrent use with bypassing agents
- Articulate the role of genetic testing in the identification of potential carriers and women with hemophilia and the hemostatic management recommendations during pregnancy, labor and delivery, and the postpartum phases
Faculty w/ credentials
- Jennifer Maahs, MSN, PNP, RN-BC
- Amy Shapiro, MD
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 80% or better.
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 2.0 ANCC contact hour(s). This activity is provided for 0.3 contact hours related to pharmacotherapeutic content. Nurses should only claim credit for the actual time spent participating in the activity.
PHYSICIAN ASSISTANTS
University of Nebraska Medical Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2 AAPA Category 1 CME credits. Approval is valid until February 23, 2024. PAs should only claim credit commensurate with the extent of their participation.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
A School Nurse's Guide to Sickle Cell Disease
- Credits: 0.5 (ANCC)
- Expiration Date: August 18, 2023
A School Nurse's Guide to Sickle Cell Disease Details
Activity Number and Title
21HT00091 - A School Nurse's Guide to Sickle Cell Disease
Release Date
August 18, 2021
Expiration Date
5:00 PM Eastern, August 18, 2023
The estimated time to complete this activity is 30 minutes.
Purpose Statement
The purpose of this activity is to enable the learner to gain knowledge on the etiology, symptoms, treatment of sickle cell disease, and management strategies in order to optimize safety and learning for affected students.
Activity Description
This module will present the causes, disease traits, inheritance, and symptoms of sickle cell disease (SCD). In addition, common problems and complications of SCD including pain, stroke, priapism, acute chest syndrome, infection, bone disease, eye disease, and other health problems will be provided. Strategies and special accommodations that can be used in the school setting will also be presented.
Target Audience
This enduring material is intended for professional school nurses in schools attended by a child with sickle cell disease (SCD), teachers, physical education teachers, administrators and guidance counselors, and other school staff or health care professionals who require an introduction to school-related considerations for students with SCD.
Educational Objectives
At the conclusion of this enduring material, the participants should be better able to:
- Describe basic information related to the etiology and symptoms of sickle cell disease (SCD)
- Identify common challenges for students with SCD and interventions utilized within the school setting
- Integrate strategies and accommodations in the school setting to promote a safe and positive learning environment for students with SCD
Faculty
- Ellen Bloom, MPH, CHES
- Kisha Hampton, MPH
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Statement and Contact Hours
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia and Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 0.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
Gene Therapy 101 for Patients and Families Details
Activity Number and Title
Gene Therapy 101 for Patients and Families
Release Date
April 25, 2022
Expiration Date
N/A
Activity Description
Although the volume of health care content on the internet has increased over the past several years, patients with hemophilia often experience difficulty with information on new treatments. This being the case, these patients will ask for guidance from their healthcare providers.
Authors Dr. Len Valentino and Jim Munn have arranged this module as a journey through the process of informed consent for patients who are considering receiving gene therapy for hemophilia. This includes:
- Shared decision making with the healthcare provider
- How gene therapy works
- The goals of gene therapy
- A review of treatment and possible side effects
- What to expect after receiving gene therapy
Faculty
- Len Valentino, MD
- Jim Munn, MS, BSN, RN-BC
Financial Support
Supported by an educational grant from BioMarin Pharmaceutical Inc., in collaboration with the American Thrombosis and Hemostasis Network, Inc. and the National Hemophilia Foundation.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Explorer
- Cookies and JavaScript must be enabled in the browser
The Partners in Bleeding Disorders Education Program is supported by educational grants from Takeda Pharmaceuticals U.S.A., Inc; Genentech, a member of the Roche Group; the National Hemophilia Foundation (NHF); and the Hemophilia Alliance.
Copyright © 2022 Indiana Hemophilia & Thrombosis Center. All rights reserved. Privacy Policy | Travel Policy | Terms of Service Credits